ArticleJournal of thoracic disease2026
Prevalence and malignancy risk of incidental pulmonary nodules: insights from a retrospective study in Saudi Arabia.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Incidental pulmonary nodules (IPNs) are frequently identified in computed tomography (CT) scans performed for unrelated clinical indications. While most are benign, some harbor malignancy, necessitating proper evaluation. This study assesses the prevalence, characteristics, and malignancy predictors of IPNs. Methods: A retrospective review of CT scans conducted between January 2015 and December 2022 at a single institution was performed. From 16,433 CT reports, 749 cases of pulmonary nodules were identified, of which 219 met inclusion criteria. Of 219 incidental nodules identified, 103 (47%) had follow-up CT imaging and comprised the analytic cohort for outcome assessment. Demographic and clinical data, including smoking history and nodule characteristics, were analyzed. Malignancy was confirmed through histopathological examination. Statistical analyses included descriptive comparisons and penalized logistic regression to account for low event rates. Results: The study involved 219 patients with an equal sex distribution. The median nodule count was 5 per patient, with a median size of 5 mm. Most nodules were in the right upper lobe. Malignancy was detected in 5 of 103 patients with follow-up imaging (4.85%), which is significantly higher compared with national registry data of the general population. While malignant nodules exhibited slightly larger median sizes (6.5 mm), they did not significantly differ from benign ones in terms of size distribution or lobar location (P>0.05). Patients above 50 years old showed a significantly higher number of nodules (P=0.002). Conclusions: A significant proportion of IPNs in this cohort demonstrated malignancy risk, highlighting important gaps in follow-up and documentation in routine clinical practice. These findings highlight the need for structured, risk-based follow-up protocols to ensure timely evaluation while avoiding unnecessary interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.